The FTC and the states of Utah and California sued Hims & Hers, alleging it improperly shared consumers’ health information ...

Johnson & Johnson also gains an exclusive option to acquire Sail Biosciences for $2.58 billion. The deal puts J&J in the mix ...

MedCity News' new event for healthcare investors and corporate business development leads — Bullseye — hit the mark when it ...

A new analysis from the American Medical Association (AMA) adds to the growing evidence detailing the lack of competition and high vertical integration in the pharmacy benefit manager market. The ...

A BridgeBio Pharma drug developed for dwarfism increased children’s growth rates in a pivotal clinical trial, meeting the study’s main goal and boosting the daily pill’s chances to offer an ...

Doctronic acquired Summer Health to expand into pediatric care and strengthen its AI-powered primary care platform.

With the merger, Processa’s new lead asset is a Vidya Therapeutics immunology drug that offers pipeline-in-a-product ...

This roundup is published monthly. It is meant to highlight some of healthcare’s recent hiring news and is not intended to be comprehensive. If you have news about an executive appointment, ...

Access to sleep medicine is a worldwide problem, with about 80% of people with sleep apnea remaining undiagnosed. Several startups are using AI to try and address this issue — and on Wednesday, one of ...

A survey of 112 health system executives finds that Epic's hold on hospital IT keeps getting stronger — but startups still ...

Roughly 31,000 Kaiser Permanente nurses and other healthcare professionals are planning to launch an open-ended strike starting on Monday. Their main grievances are chronic understaffing, rising ...

Two obesity drugs are among the six new medications that could get faster FDA review under a new pilot program open to products addressing certain national health priorities. Rare and infectious ...